Marked increase in bladder and lung cancer mortality in a region of northern chile due to arsenic in drinking water

American Journal of Epidemiology

Volumn 147, Issue 7, 1998, Pages 660-669

  Smith, Allan H ^a   Goycolea, Mario ^b   Haque, Reina ^a   Biggs, Mary Lou ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Servicio de Salud de Antofagasta   (Chile)

Author keywords

Arsenic; Bladder neoplasms; Lung neoplasms; Mortality

Indexed keywords

ARSENIC; DRINKING WATER;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER MORTALITY; CHILE; FEMALE; HUMAN; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; SKIN CANCER;

EID: 0032054940     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009507     Document Type: Article

References (36)

1. International Agency for Research on Cancer. Some metals and metallic compounds. (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 23). Lyon, France: International Agency for Research on Cancer, 1980.
2. Chen CJ, Chuang YC, Lin TM, et al. Malignant neoplasms among residents of a Blackfoot Disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 1985;45:5895-9.
3. Chen CJ, Chuang YC, You SL, et al. A retrospective study on malignant neoplasms of bladder, lung and liver in Blackfoot Disease endemic area in Taiwan. Br J Cancer 1986;53:399-405.
4. Chen CJ, Kuo TL, Wu MM. Arsenic and cancers. (Letter). Lancet 1988;1:414-15.
5. Chen CJ, Wu MM, Lee SS, et al. Atherogenicity and carcinogenicity of high-arsenic artesian well water; multiple risk factors and related malignant neoplasms of Blackfoot Disease. Arteriosclerosis 1988;8:452-460.
6. Wu MM, Kuo TL, Hwang YH, et al. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 1989;130:1123-32.
7. Chen CJ, Chen CW, Wu MM, et al. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 1992;66:888-92.
8. Bates MN, Smith AH, Hopenhayn-Rich C. Arsenic ingestion and internal cancers: a review. Am J Epidemiol 1992;135:462-76.
9. Chiou HY, Hsueh YM, Liaw KF, et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 1995;55:1296-1300.
10. Smith AH, Hopenhayn-Rich C, Bates MN, et al. Cancer risks from arsenic in drinking water. Environ Health Perspect 1992;97:259-67.
11. Hopenhayn-Rich C, Biggs ML, Fuchs A, et al. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiol 1996;7:117-124.
12. Cuzick J, Sasieni P, Evans S. Ingested arsenic, keratoses, and bladder cancer. Am J Epidemiol 1992;136:417-421.
13. Tsuda T, Nagira T, Yamamoto M, et al. An epidemiological study on cancer in certified arsenic poisoning patients in Toroku. Ind Health 1990;28(2):53-62.
14. Borgono JM, Vicent P, Venturino H, et al. Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of a treatment plant. Environ Health Perspect 1977;19:103-105.
15. Sancha AM, Vega F, Venturino H, et al. The arsenic health problem in Northern Chile. Evaluation and control. A case study preliminary report. In: Sancha FAM, ed. International Seminar Proceedings Arsenic in the Environment and Its Incidence on Health. Universidad De Chile, Facultad De Ciencias Fisicas y Matematicas, Santiago, Chile, May 25-29, 1992:187-202.
16. Zaldivar R, Villar I, Robinson H, et al. Chronic arsenic poisoning. Epidemiological, clinical, pathological, toxicological and nutritional data. Rev Med Chil 1978;106:1027-30.
17. Arroyo-Meneses A. Hidroarsenicismo cronico en la region de Antofagasta. In: Primera Jornada Sobre Arsenicismo Laboral y Ambiental II Region. Antofagasta, Republica de Chile, Ministerio de Salud, Servicio De Salud Antofagasta Departmento de Programas Sobre El Ambiente, y Asociacion Chilena de Seguridad, 1991:35-47.
18. Cebrian M, Albores A, Camara V, et al. Heavy metals. In: Finkelman J, Corey G, Calderon R, eds. Environmental epidemiology: a project for Latin America and the Caribbean. Metepec, Mexico: Pan American Center for Human Ecology and Health, World Health Organization, 1993:95-145.
19. Breslow NE, Day NE. Statistical methods in cancer research. Vol IL The design and analysis of cohort studies. (IARC Scientific Publications no. 82). Lyon, France: International Agency for Research on Cancer, 1987.
20. Ministerio de Planificacion y Cooperacion Nacional Republica de Chile. IIIa Encuesta CASEN (Caracterizacion Socio Economica Nacional), Nov 1990. Santiago de Chile: Alfa Beta Empresores, 15 Ed, 1992:257-70, 305-7.
21. Cornejo-Catalan J. Panorama del arsenicismo en la II region. In: Primera Jornada Sobre Arsenicismo Laboral y Ambiental II Region. Antofagasta, Republica de Chile, Ministerio de Salud, Servicio de Salud Antofagasta Departmento de Programas Sobre El Ambiente, y Asociacion Chilena de Seguridad, 1991:15-34.
22. Venturino Ponce H. Determinacion de concentracion de arsenico urinario en diferentes regiones de Chile. In: Primera Jornada Sobre Arsenicismo Laboral y Ambiental II. Antofagasta, Republica de Chile, Ministerio de Salud, Servicio De Salud Antofagasta Departmento de Programas Sobre El Ambiente, y Asociacion Chilena de Seguridad, 1991:49-52.
23. Greenland S, Robins J. Invited commentary: Ecologic studies - biases, misconceptions, and counterexamples. Am J Epidemiol 1994;139:747-60.
24. Silverman DT, Hartge P, Morrison AS, et al. Epidemiology of bladder cancer. Hematol Oncol Clin North Am 1992;6:1-30.
25. McLaughlin JK, Lindblad P, Mellemgaard A, et al. International renal-cell cancer study. I. Tobacco use. Int J Cancer 1995;60:194-8.
26. Axelson O. Aspects on confounding in occupational health epidemiology. Scand J Work Environ Health 1978;4:85-9.
27. Rosenberg HG. Systemic arterial disease and chronic arsenicism in infants. Arch Pathol 1974;97:360-5.
28. Guha Mazumder DM, Das Gupta J, Santra A, et al. Non-cancer effects of chronic arsenicosis with special reference to liverdamage. In: Abernathy CO, Calderon RL, Chappell WR, eds. Arsenic: exposure and health effects. London: Chapman and Hall, 1997:112-23.
29. Botha JL, Irwig LM, Strebel PM. Excess mortality from stomach cancer, lung cancer, and asbestosis and/or mesothelioma in crocidolite mining districts in South Africa. Am J Epidemiol 1986;123:30-40.
30. Yeh FS, Yu MC, Mo CC, et al. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 1989;49:2506-9.
31. Parkin DM, Pisani P, Lopez AD, et al. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 1994;59:494-504.
32. Bates MN, Smith AH, Cantor KP. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 1995;141:523-30.
33. Hopenhayn-Rich C, Biggs ML, Smith AH, et al. Methylation study in a population environmentally exposed to arsenic in drinking water. Environ Health Perspect 1996;104:620-8.
34. Hopenhayn-Rich C, Biggs ML, Kalman DA, et al. Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ Health Perspect 1996;104:1200-7.
35. Shirachi DY, Johansen MG, McGowan JP, et al. Tumorigenic effect of sodium arsenite in rat kidney. Proc West Pharmacol 1983;26:413-15.
36. Yamamoto S, Konishi Y, Matsuda T, et al. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res 1995;55:1271-6.